Navigation Links
338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
Date:9/4/2008

of side effects, most commonly local tissue reactions near the injection site, was generally lower for patients treated with Polidocanol than for patients treated with STS.

"We are very pleased that the EASI study successfully demonstrated the safety and the efficacy of Polidocanol for the treatment of spider and reticular veins," said Professor Eberhard Rabe, President of the International Union of Phlebology (UIP) and the German Society of Phlebology (DGP) and Professor at the Department of Dermatology, University of Bonn, and the principal investigator in the study. "Polidocanol has been used successfully to treat spider and reticular veins in Europe for over 40 years, and we are pleased to participate in this clinical evaluation to evaluate Polidocanol. These results scientifically confirm our every day experience in clinical practice, and the high patient satisfaction seen with Polidocanol, as compared to STS."

The EASI Study results will be presented at several scientific congresses in the coming weeks by Professor Eberhard Rabe, the principal investigator in the study. Planned presentations include September 8, 2008, at the Australasian College of Phlebology meeting in Australia, November 7, 2008, at the American College of Phlebology, and November 9, 2008, at the American Society of Dermatologic Surgery late-breaking results session.

"We are delighted with the results of this clinical study," said Steve Basta, Chief Executive Officer of BioForm Medical, Inc. "We believe that bringing Polidocanol into the U.S. market will allow physicians in the United States to use what has been regarded internationally as the gold standard product for sclerotherapy, and that the lower rate of local tissue reactions evidenced in this trial versus the leading competing product, combined with the high success rate of this treatment may be the basis of significant future growth in sclerotherapy procedure volume in the United States upon FDA approval and th
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients
2. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
3. Agendia Launches TargetPrint(R) for Breast Cancer Patients
4. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
5. Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
6. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
7. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
8. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
9. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
10. TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
11. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to ... company developments. As Medifirst continues to expand its business, ... Integrating social media into its investor relations strategy, the ... updates on Twitter.  The Facebook homepage is Medifirst Solutions ... Says CEO Bruce J. Schoengood , ...
(Date:5/22/2013)... 22, 2013 Ranbaxy Laboratories Limited (hereafter, ... (hereafter, Daiichi Sankyo), announced on May 22 the ... to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in its ... the past which led to the investigations by ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta ... developer and provider of microRNA-based molecular diagnostics, announces that ... Chief Executive Officer of Rosetta Genomics, will deliver a ... place from June 3-6, 2013 in New York City.  ... 4 th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...
(Date:5/22/2013)... Ky. (PRWEB) May 22, 2013 ... Marathon bombings and the school shooting in Newtown, ... to children. , Emergency medical practitioners ... emergencies, and the Emergency Medical Services for Children ... for quality care for the youngest patients. It ...
(Date:5/22/2013)... FL (PRWEB) May 22, 2013 Space ... on as a sponsor for this weekend's I Talk to ... place at 8:00 am at Cocoa Riverside Park in Cocoa, ... through the I Talk to Strangers social movement. , As ... runners and walkers to participate in the event. Additionally, they ...
(Date:5/22/2013)... 2013 Pamela Isom, President and CEO ... Business Journal’s 2013 Women of Influence Award in recognition ... , The reception took place on Thursday, May 2 ... Influence is particularly humbling for the 5,000 people ICE ... success is to recognize the four to nine lives ...
(Date:5/22/2013)... Homeopathic Vibes is implementing new store hours to better ... during normal hours. On Wednesdays, they will now be open ... of our patients who work shifts that won’t allow them ... says owner and homeopathic consultant, Harminder Singh. Their normal hours, ... through Friday; weekends are by appointment only. , Out ...
Breaking Medicine News(10 mins):Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:Homeopathic Vibes Now Open Late on Wednesdays 2
... World Health Organization expected to make recommendation next week, ... Vaccine manufacturers and other health experts met Thursday at ... plot potential strategies to combat the swine flu virus ... infection worldwide. , The Associated Press reported ...
... In conjunction with CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, ... Internet on Thursday, June 4th at 11:30 am Eastern Time., Event: ... Hosted by: Dan Starck, President and CEO, ... Chairman, Date: 11:30 am ...
... OAK BROOK, Ill. May 14, 2009 In ... Barrett,s esophagus, electronic diagnosis overestimated the prevalence of the ... only 61.9 percent of patients assigned a billing diagnosis ... a manual record review. The study evaluated the accuracy ...
... country join forces to advocate for more research funding ... we continue to mark Food Allergy Awareness Week, Robert ... of the Food Allergy Initiative (FAI), announced the formation ... are to help build a strong nationwide presence for ...
... May 14 If the H1N1 pandemic flu follows the ... with more vigor in a second wave next fall. In ... unusual rapidity, resulting in 3 explosive pandemic waves within a ... for the Prudent Use of Antibiotics and Microbiology Lab Director ...
... of life over 8 years of follow-up, study finds, ... (ICDs) extend heart patients, lives even eight years after ... be presented Thursday at the Heart Rhythm Society annual ... ICD therapy, sustained for over eight years, does in ...
Cached Medicine News:Health News:Health Experts Plot Strategy for Swine Flu Vaccine 2Health News:Health Experts Plot Strategy for Swine Flu Vaccine 3Health News:Health Experts Plot Strategy for Swine Flu Vaccine 4Health News:Health Experts Plot Strategy for Swine Flu Vaccine 5Health News:Health Experts Plot Strategy for Swine Flu Vaccine 6Health News:Health Experts Plot Strategy for Swine Flu Vaccine 7Health News:Health Experts Plot Strategy for Swine Flu Vaccine 8Health News:Health Experts Plot Strategy for Swine Flu Vaccine 9Health News:CorVel Announces Fiscal Year Earnings Release Webcast 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 2Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 3Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 4Health News:Study examines reliability of clinical and pathological diagnoses of Barrett's esophagus 5Health News:Robert F. Kennedy, Jr. Announces New Food Allergy Initiative Advocacy Steering Committee 2Health News:Robert F. Kennedy, Jr. Announces New Food Allergy Initiative Advocacy Steering Committee 3Health News:H1N1 Pandemic Precautions for Front Line Workers 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: